NCT01772381

Brief Summary

Introduction: Babies born at term by elective caesarean section (CS) and before onset of labor are more likely to develop respiratory complications than babies born vaginally. In developing countries resources are scarce and it is difficult to provide expensive treatments as neonatal care. Aim of the Work: To assess the effect of prophylactic dexamethasone administration before elective cesarean section at term in reducing neonatal respiratory complications. Patients and methods: 600 women were included in the study and were planned to have elective caesarean section. 300 received dexamethasone 12 mg twice, 12 hours apart 48 hours before delivery. 300 patients were the control group. The outcomes were: incidence of admission to neonatal intensive care unit (NICU), incidence of transient tachypnea of newborn (TTN), the incidence of respiratory distress syndrome (RDS) and the need for mechanical ventilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 31, 2012

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 21, 2013

Completed
Last Updated

January 21, 2013

Status Verified

January 1, 2013

Enrollment Period

1 year

First QC Date

December 31, 2012

Last Update Submit

January 18, 2013

Conditions

Keywords

Dexamethasone, term, elective cesarean section

Outcome Measures

Primary Outcomes (1)

  • Special care baby unit

    Special care baby unit admission for babies with respiratory distress

    24 hours

Secondary Outcomes (1)

  • Severity of respiratory distress

    24 hours

Study Arms (1)

Dexamethasone

EXPERIMENTAL

Dexamethasone, im , 12 mg twice, 12 hrs apart, 48 hrs before elective cesarean section

Drug: Dexamethasone

Interventions

Long acting corticosteroid

Also known as: Decadron
Dexamethasone

Eligibility Criteria

Age22 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Previous caesarean section
  • Complete 37 week calculated from the first day of the last menstrual period.

You may not qualify if:

  • Obstetric complications such as pre-eclampsia, antepartum hemorrhage or known fetal anomaly.
  • Hypertensive patients.
  • Chronic disease e.g. diabetes mellitus.
  • Known renal disease.
  • Pre-operative infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams Maternity Hospital

Cairo, Egypt

Location

Related Publications (1)

  • Sotiriadis A, McGoldrick E, Makrydimas G, Papatheodorou S, Ioannidis JP, Stewart F, Parker R. Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes. Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4.

MeSH Terms

Conditions

Transient Tachypnea of the Newborn

Interventions

DexamethasoneCalcium Dobesilate

Condition Hierarchy (Ancestors)

Respiratory Distress Syndrome, NewbornRespiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersTachypneaInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedBenzenesulfonatesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur Compounds

Study Officials

  • Noha H Rabei, MD

    Ain Shams Maternity Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Obstetrics and Gynecology

Study Record Dates

First Submitted

December 31, 2012

First Posted

January 21, 2013

Study Start

March 1, 2010

Primary Completion

March 1, 2011

Study Completion

June 1, 2011

Last Updated

January 21, 2013

Record last verified: 2013-01

Locations